<DOC>
	<DOCNO>NCT02295488</DOCNO>
	<brief_summary>Currently , protocol use desensitization Hymenoptera venom consist rapid increase dose venom extract administer SIT day without systemic reaction patient yet explain . The hypothesis good tolerance due rapid decrease response mast cell basophils allergen.. The main objective study basophil activation response allergen first day desensitization , measure basophil activation test . The initiation desensitization follow protocol rapid growth rate . The basophil activation level course desensitization analyze flow cytometry vitro stimulation allergen . Changes T cell polarization also analyze flow cytometry . Evolution expression different protein blood basophil study measure messenger RNAs</brief_summary>
	<brief_title>Determinism Mechanism Action Specific Immunotherapy Hymenoptera Venom Allergy</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<criteria>Patients 18 year 75 year age Patient present generalized allergic reaction puncture hymenoptera Patient positive skin test venom hymenoptera Patient positive specific IgE venom hymenoptera â€¢ indication accelerate desensitization choose day hospitalization Information consent sign patient Patient affiliate french social security system For woman childbearing age , take effective contraceptive . Patients follow disease : Mastocytosis , systemic infection hospitalization within 4 week inclusion , chronic inflammatory disease , cancer , unbalanced asthma , immune deficiency Patients betablocker , follow another specific immunotherapy , ongoing immunosuppressive therapy . Pregnant lactate People place judicial protection Patient participate participate another biomedical research within six month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>hymenoptera puncture</keyword>
</DOC>